Avanos Medical, Inc. (NYSE:AVNS) Shares Sold by New York State Teachers Retirement System

New York State Teachers Retirement System trimmed its stake in Avanos Medical, Inc. (NYSE:AVNS) by 12.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 78,006 shares of the company’s stock after selling 10,600 shares during the quarter. New York State Teachers Retirement System owned approximately 0.17% of Avanos Medical worth $1,750,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in AVNS. William Blair Investment Management LLC acquired a new position in Avanos Medical in the third quarter valued at $22,134,000. Norges Bank acquired a new position in Avanos Medical in the fourth quarter valued at $11,055,000. Goldman Sachs Group Inc. increased its stake in Avanos Medical by 24.5% in the first quarter. Goldman Sachs Group Inc. now owns 1,998,871 shares of the company’s stock valued at $66,962,000 after purchasing an additional 392,870 shares during the last quarter. Macquarie Group Ltd. increased its stake in Avanos Medical by 21.4% in the first quarter. Macquarie Group Ltd. now owns 1,987,355 shares of the company’s stock valued at $59,104,000 after purchasing an additional 349,799 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in Avanos Medical by 9.8% in the first quarter. Dimensional Fund Advisors LP now owns 3,173,794 shares of the company’s stock valued at $94,387,000 after purchasing an additional 281,958 shares during the last quarter. 95.17% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Avanos Medical

In other news, CFO Michael Greiner sold 8,000 shares of the company’s stock in a transaction dated Thursday, March 14th. The stock was sold at an average price of $19.12, for a total value of $152,960.00. Following the completion of the sale, the chief financial officer now owns 151,495 shares of the company’s stock, valued at $2,896,584.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.94% of the stock is owned by company insiders.

Avanos Medical Price Performance

AVNS stock opened at $18.66 on Wednesday. The stock has a 50-day moving average price of $19.34 and a two-hundred day moving average price of $19.99. Avanos Medical, Inc. has a 12-month low of $17.24 and a 12-month high of $31.31. The company has a current ratio of 2.08, a quick ratio of 1.38 and a debt-to-equity ratio of 0.13. The company has a market cap of $862.09 million, a PE ratio of -14.13, a price-to-earnings-growth ratio of 1.08 and a beta of 0.96.

Avanos Medical (NYSE:AVNS) last posted its quarterly earnings results on Tuesday, February 20th. The company reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.37 by ($0.01). Avanos Medical had a negative net margin of 8.76% and a positive return on equity of 4.25%. The firm had revenue of $173.30 million for the quarter, compared to analysts’ expectations of $170.43 million. During the same period last year, the firm posted $0.60 EPS. Avanos Medical’s revenue was down 4.6% on a year-over-year basis. As a group, research analysts predict that Avanos Medical, Inc. will post 1.38 EPS for the current year.

Analyst Upgrades and Downgrades

Separately, StockNews.com upgraded Avanos Medical from a “hold” rating to a “buy” rating in a research note on Tuesday, March 19th.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.